How has Denali Therapeutics Inc.'s interest income and other, net changed year-over-year?

Denali Therapeutics Inc.'s interest income and other, net decreased by 29.3% year-over-year, from $12.61M to $8.91M.

What is the long-term trend for Denali Therapeutics Inc.'s interest income and other, net?

Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s interest income and other, net has grown at a 42.7% compound annual growth rate (CAGR), from $14.77M to $42.9M.

Denali Therapeutics Inc. DNLI Interest income and other, net

Interest income and other, net at other companies

BioCryst PharmaceuticalsBCRX

——

Segments

By segment

See full

Therapeutics Segment$8.91M-29.3%

Other financials

Income statement

See full

Revenue-—

Operating income-$137.4M+5.6%

Net income-$128.4M+3.4%

EPS (diluted)-$0.69+11.5%

Balance sheet

See full

Cash & equivalents$390.7M+551%

Total debt$40.0M-22.3%

Total equity$926.1M-17.5%

Total assets$1.3B-0.4%

Cash flow

See full

Operating cash flow-$131.2M+0.2%

CapEx$2.5M-51.4%

Free cash flow-$133.7M+2.1%

Valuation

See full

Market cap$3.93B+54.2%

Profitability

See full

Operating margin-37,938%-37,986pp

Net margin-33,121.9%-33,159pp

FCF margin-31,736.3%-31,830pp

Returns & leverage

See full

Return on equity-49.6%+34.2pp

Debt / equity0×0.0×

Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Denali Therapeutics Inc.'s interest income and other, net?: Denali Therapeutics Inc. (DNLI) reported interest income and other, net of $8.91M in Q1 2026.
How has Denali Therapeutics Inc.'s interest income and other, net changed year-over-year?: Denali Therapeutics Inc.'s interest income and other, net decreased by 29.3% year-over-year, from $12.61M to $8.91M.
What is the long-term trend for Denali Therapeutics Inc.'s interest income and other, net?: Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s interest income and other, net has grown at a 42.7% compound annual growth rate (CAGR), from $14.77M to $42.9M.